146 related articles for article (PubMed ID: 31102802)
1. Rapid and continuous accumulation of nitric oxide-releasing liposomes in tumors to augment the enhanced permeability and retention (EPR) effect.
Yoshikawa T; Mori Y; Feng H; Phan KQ; Kishimura A; Kang JH; Mori T; Katayama Y
Int J Pharm; 2019 Jun; 565():481-487. PubMed ID: 31102802
[TBL] [Abstract][Full Text] [Related]
2. S-Nitrosated human serum albumin dimer as novel nano-EPR enhancer applied to macromolecular anti-tumor drugs such as micelles and liposomes.
Kinoshita R; Ishima Y; Ikeda M; Kragh-Hansen U; Fang J; Nakamura H; Chuang VT; Tanaka R; Maeda H; Kodama A; Watanabe H; Maeda H; Otagiri M; Maruyama T
J Control Release; 2015 Nov; 217():1-9. PubMed ID: 26302904
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation of a nitric oxide donor into a liposome to boost the enhanced permeation and retention (EPR) effect.
Tahara Y; Yoshikawa T; Sato H; Mori Y; Zahangir MH; Kishimura A; Mori T; Katayama Y
Medchemcomm; 2017 Feb; 8(2):415-421. PubMed ID: 30108759
[TBL] [Abstract][Full Text] [Related]
4. Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.
Kinoshita R; Ishima Y; Chuang VTG; Nakamura H; Fang J; Watanabe H; Shimizu T; Okuhira K; Ishida T; Maeda H; Otagiri M; Maruyama T
Biomaterials; 2017 Sep; 140():162-169. PubMed ID: 28651144
[TBL] [Abstract][Full Text] [Related]
5. Polymer nitric oxide donors potentiate the treatment of experimental solid tumours by increasing drug accumulation in the tumour tissue.
Studenovsky M; Sivak L; Sedlacek O; Konefal R; Horkova V; Etrych T; Kovar M; Rihova B; Sirova M
J Control Release; 2018 Jan; 269():214-224. PubMed ID: 29154977
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of the Enhanced Permeability and Retention Effect with Nitric Oxide-Generating Agents Improves the Therapeutic Effects of Nanomedicines.
Islam W; Fang J; Imamura T; Etrych T; Subr V; Ulbrich K; Maeda H
Mol Cancer Ther; 2018 Dec; 17(12):2643-2653. PubMed ID: 30232144
[TBL] [Abstract][Full Text] [Related]
7. Polymer donors of nitric oxide improve the treatment of experimental solid tumours with nanosized polymer therapeutics.
Šírová M; Horková V; Etrych T; Chytil P; Říhová B; Studenovský M
J Drug Target; 2017; 25(9-10):796-808. PubMed ID: 28726521
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation of N-Diazeniumdiolates within Liposomes for Enhanced Nitric Oxide Donor Stability and Delivery.
Suchyta DJ; Schoenfisch MH
Mol Pharm; 2015 Oct; 12(10):3569-74. PubMed ID: 26287799
[TBL] [Abstract][Full Text] [Related]
9. Simultaneously overcome tumor vascular endothelium and extracellular matrix barriers via a non-destructive size-controlled nanomedicine.
Wang B; Zhai Y; Shi J; Zhuang L; Liu W; Zhang H; Zhang H; Zhang Z
J Control Release; 2017 Dec; 268():225-236. PubMed ID: 29054372
[TBL] [Abstract][Full Text] [Related]
10. A mathematical model of the enhanced permeability and retention effect for liposome transport in solid tumors.
Stapleton S; Milosevic M; Allen C; Zheng J; Dunne M; Yeung I; Jaffray DA
PLoS One; 2013; 8(12):e81157. PubMed ID: 24312530
[TBL] [Abstract][Full Text] [Related]
11. Effect of an Endothelin B Receptor Agonist on the Tumor Accumulation of Nanocarriers.
Feng H; Nam LT; Yoshikawa T; Kishimura A; Mori T; Katayama Y
Biol Pharm Bull; 2020; 43(9):1301-1305. PubMed ID: 32879203
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the Accumulation of Polymer Micelles by Selectively Dilating Tumor Blood Vessels with NO for Highly Effective Cancer Treatment.
Wei G; Wang Y; Huang X; Yang G; Zhao J; Zhou S
Adv Healthc Mater; 2018 Dec; 7(24):e1801094. PubMed ID: 30565900
[TBL] [Abstract][Full Text] [Related]
13. Modification of nitric oxide donors onto a monoclonal antibody boosts accumulation in solid tumors.
Yoshikawa T; Phan KQ; Tagawa H; Sasaki K; Feng H; Kishimura A; Mori T; Katayama Y
Int J Pharm; 2020 Jun; 583():119352. PubMed ID: 32325243
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors.
Kibria G; Hatakeyama H; Sato Y; Harashima H
Int J Pharm; 2016 Jul; 509(1-2):178-187. PubMed ID: 27234700
[TBL] [Abstract][Full Text] [Related]
15. Accumulating nanoparticles by EPR: A route of no return.
Ngoune R; Peters A; von Elverfeldt D; Winkler K; Pütz G
J Control Release; 2016 Sep; 238():58-70. PubMed ID: 27448444
[TBL] [Abstract][Full Text] [Related]
16. Sonoporation enhances liposome accumulation and penetration in tumors with low EPR.
Theek B; Baues M; Ojha T; Möckel D; Veettil SK; Steitz J; van Bloois L; Storm G; Kiessling F; Lammers T
J Control Release; 2016 Jun; 231():77-85. PubMed ID: 26878973
[TBL] [Abstract][Full Text] [Related]
17. Intra-tumor distribution of PEGylated liposome upon repeated injection: No possession by prior dose.
Nakamura H; Abu Lila AS; Nishio M; Tanaka M; Ando H; Kiwada H; Ishida T
J Control Release; 2015 Dec; 220(Pt A):406-413. PubMed ID: 26548975
[TBL] [Abstract][Full Text] [Related]
18. Drug Delivery System for Refractory Cancer Therapy via an Endogenous Albumin Transport System.
Ishima Y; Maruyama T; Otagiri M; Ishida T
Chem Pharm Bull (Tokyo); 2020; 68(7):583-588. PubMed ID: 32611995
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors.
Danhier F; Danhier P; De Saedeleer CJ; Fruytier AC; Schleich N; des Rieux A; Sonveaux P; Gallez B; Préat V
Int J Pharm; 2015 Feb; 479(2):399-407. PubMed ID: 25578367
[TBL] [Abstract][Full Text] [Related]
20. Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis.
Liu R; Xiao W; Hu C; Xie R; Gao H
J Control Release; 2018 May; 278():127-139. PubMed ID: 29630985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
